CDAI (Clinical Disease Activity Index) Calculator

The CDAI (Clinical Disease Activity Index) Calculator calculates disease activity in rheumatoid arthritis from joint counts and global assessments, providing a score and activity category.

CDAI (Clinical Disease Activity Index) Calculator Explained

The Clinical Disease Activity Index is a standardized score used to assess rheumatoid arthritis (RA) activity. It is the sum of four parts: tender joints, swollen joints, patient global assessment, and provider global assessment. The joint counts cover 28 specific joints in the hands, elbows, shoulders, and knees. Global assessments typically use a 0–10 scale for how active the disease feels or appears.

CDAI ranges from 0 to 76. Lower scores indicate less disease activity. Thresholds define categories that guide decisions: remission, low, moderate, and high disease activity. Because CDAI does not depend on laboratory values, it is practical in routine visits and telemedicine.

The score correlates with function, pain, and long-term outcomes. It is sensitive to change, so it can track response to treatment. CDAI complements other indices like DAS28 but is simpler to compute and interpret at the bedside.

CDAI (Clinical Disease Activity Index) Formulas & Derivations

The index is a straightforward sum of four validated components. Each component has a defined range, and the total maps to clinical categories. The arithmetic lends itself to manual checks, audit trails, and rapid verification.

• Core formula: CDAI = Swollen Joint Count (28 joints) + Tender Joint Count (28 joints) + Patient Global Assessment (0–10) + Provider Global Assessment (0–10).
• Allowed ranges: TJC28 = 0–28, SJC28 = 0–28, Patient and Provider global assessments each = 0–10 (same scale). Total range = 0–76.
• Category thresholds (standard): Remission ≤ 2.8; Low > 2.8 to ≤ 10; Moderate > 10 to ≤ 22; High > 22.
• Scale conversion: If globals are captured on a 0–100 mm Visual Analog Scale, divide by 10 to convert to a 0–10 scale.
• No multiplicative weights are used; all components contribute linearly. This makes category transitions easy to interpret.

If your clinic uses a 0–100 mm line, convert consistently before summing. Keep the same scale across visits for comparability. Decimals are acceptable for global assessments, and most teams round the final CDAI to one decimal for reporting.

How the CDAI (Clinical Disease Activity Index) Method Works

CDAI blends objective joint counts with global impressions from both the patient and the clinician. The 28-joint count focuses on joints most affected in RA, ensuring standardization across evaluations. Patient and provider assessments reflect overall disease activity over the recent period, commonly the past week.

• Count tender joints across the standard 28 joints (TJC28), using palpation and patient feedback.
• Count swollen joints across the same 28 joints (SJC28), focusing on synovitis, not bony enlargement.
• Record the Patient Global Assessment (PtGA) on a 0–10 scale, where 0 is “no activity” and 10 is “very active disease.”
• Record the Provider Global Assessment (PhGA) on the same 0–10 scale.
• Convert globals if needed (e.g., 0–100 mm to 0–10 by dividing by 10) to align scales.
• Add the four values to obtain the CDAI score, then compare it with the category thresholds.

Because the method is additive, changes in any component shift the total. This supports nuanced clinical decisions, such as escalating therapy if swelling persists or investigating non-inflammatory pain when globals remain high despite low joint counts.

Inputs, Assumptions & Parameters

The calculator relies on four inputs and a clear choice of scale. Accurate joint examination and consistent scaling ensure reliable results and clean visit-to-visit comparisons.

• TJC28 (0–28): number of tender joints among the standard 28.
• SJC28 (0–28): number of swollen joints among the standard 28.
• PtGA (0–10): patient’s overall view of RA activity on a 0–10 scale.
• PhGA (0–10): clinician’s overall view of RA activity on a 0–10 scale.
• Scale selection: Globals may be captured on a 0–10 Numeric Rating Scale or a 0–100 mm Visual Analog Scale; convert before summing.

Inputs must fall within their allowed ranges. If using a 0–100 mm line, divide by 10 to match the 0–10 metric. Avoid mixing scales between PtGA and PhGA. Handle missing values before calculation; CDAI cannot be computed with incomplete data.

How to Use the CDAI (Clinical Disease Activity Index) Calculator (Steps)

Here’s a concise overview before we dive into the key points:

1. Perform a 28-joint examination and record TJC28 and SJC28.
2. Ask the patient to rate overall RA activity using a 0–10 scale.
3. Record your clinical impression (PhGA) on the same 0–10 scale.
4. If globals are on a 0–100 mm line, divide each by 10 to convert to 0–10.
5. Enter TJC28, SJC28, PtGA, and PhGA into the calculator fields.
6. Review the computed CDAI score and the assigned category.

These points provide quick orientation—use them alongside the full explanations in this page.

Worked Examples

A 45-year-old with established RA reports mild stiffness. Exam shows TJC28 = 0 and SJC28 = 0. PtGA = 1.0 and PhGA = 1.5 on a 0–10 scale. Calculation: CDAI = 0 + 0 + 1.0 + 1.5 = 2.5. Interpretation: 2.5 is ≤ 2.8, which indicates remission. What this means: Continue current plan and monitor; consider taper only if stable and per guidelines.

A 60-year-old presents with active synovitis in hands and knees. TJC28 = 18, SJC28 = 10, PtGA = 6.5, PhGA = 5.5 (all on 0–10). Calculation: CDAI = 18 + 10 + 6.5 + 5.5 = 40. Interpretation: 40 is > 22, which indicates high disease activity. What this means: Escalate therapy and consider rapid follow-up to reassess response.

Accuracy & Limitations

CDAI is practical and responsive, but results depend on consistent technique and context. Scores can be influenced by pain sensitivity, comorbid conditions, and examiner experience. Recognize these factors when interpreting changes and categories.

• Inter-rater variability: Different clinicians may grade swelling or global activity differently.
• Scale inconsistencies: Mixing 0–10 and 0–100 mm inputs will distort the total unless converted.
• Scope: CDAI omits lab values and joints outside the 28 count, so extra-articular disease is not captured.
• Comorbidities: Fibromyalgia, mood, and sleep issues can raise patient globals without inflammatory activity.
• Measurement error: Documentation lapses and rounding can shift categories near cut points.

Use CDAI alongside clinical judgment and other data. When possible, apply the same assessor, the same scale, and the same timing between visits to minimize noise and improve trend validity.

Units and Symbols

Being precise with units ensures clean comparisons over time and across clinics. Joint counts are unitless counts. Global assessments may use centimeters or millimeters, which you can map to a 0–10 metric for consistency.

Use the ranges to validate each entry. If your clinic records globals in millimeters, divide by 10 before adding to the joint counts. Keep the same unit system across visits to preserve trend integrity.

Troubleshooting

If results look off, check the inputs and units first. Most issues arise from scale mismatches or out-of-range entries. A short review usually restores accuracy and a clear category summary.

• Verify PtGA and PhGA are on the same 0–10 scale or converted uniformly from 0–100 mm.
• Recount joints if TJC28 or SJC28 seems inconsistent with the exam narrative.
• Ensure no input exceeds its allowed range (e.g., SJC28 cannot be 32).
• Confirm decimals use a period and not a comma, depending on locale.

When scores fall near a threshold (e.g., 2.7 vs 2.9), repeat measurements or average across two assessments. Document any conversions to help future audits and comparisons.

FAQ about CDAI (Clinical Disease Activity Index) Calculator

How is CDAI different from DAS28?

DAS28 includes a lab marker (ESR or CRP), while CDAI does not. CDAI is faster to compute in clinic and correlates well with disease activity.

How often should I calculate CDAI?

Calculate at each visit when managing active RA, often every 1–3 months, and at longer intervals when the disease is stable.

Can patients self-report parts of the CDAI?

Yes, patients can record PtGA before the visit. The joint counts and PhGA require clinical assessment to maintain reliability.

How do I convert VAS 0–100 mm globals to 0–10?

Divide the millimeter value by 10. For example, 73 mm becomes 7.3 on the 0–10 scale.

Key Terms in CDAI (Clinical Disease Activity Index)

Rheumatoid Arthritis (RA)

A chronic autoimmune disease that inflames synovial joints, leading to pain, swelling, stiffness, and potential joint damage without effective treatment.

TJC28

Tender Joint Count across 28 joints; the number of joints that are tender on exam, representing the patient’s pain response to palpation or movement.

SJC28

Swollen Joint Count across 28 joints; the number of joints with clinical swelling due to synovitis, assessed by inspection and palpation.

Patient Global Assessment (PtGA)

A 0–10 rating by the patient describing overall RA activity, typically over the past week, using a numeric scale or a visual analog line.

Provider Global Assessment (PhGA)

A 0–10 rating by the clinician summarizing disease activity, synthesizing joint findings, function, and other clinical observations.

Visual Analog Scale (VAS)

A line scale (often 0–100 mm) where users mark a point that represents perceived intensity; it can be converted to a 0–10 scale by dividing by 10.

Remission

A CDAI state of minimal or no detectable disease activity; for CDAI, defined as a score ≤ 2.8 under standard thresholds.

Low, Moderate, High Disease Activity

CDAI categories used for treatment decisions: Low > 2.8 to ≤ 10; Moderate > 10 to ≤ 22; High > 22, guiding goals and therapy intensity.

Sources & Further Reading

Here’s a concise overview before we dive into the key points:

• Aletaha T, Smolen JS. The Simplified Disease Activity Index and the Clinical Disease Activity Index.
• American College of Rheumatology: Disease Activity Measures for Rheumatoid Arthritis (fact sheet)
• Treat-to-target recommendations in rheumatoid arthritis: EULAR guidance
• Aletaha D et al. CDAI-based remission and its validity in clinical practice
• Felson DT et al. ACR/EULAR provisional definition of remission in RA

These points provide quick orientation—use them alongside the full explanations in this page.